stockrowQuest Diagnostics Incorporated (DGX) vs Illumina, Inc. (ILMN)
- Quest Diagnostics Incorporated DGX 254.25 −0.56%
- Illumina, Inc. ILMN 209.82 −7.38%
Quest Diagnostics Incorporated and Illumina, Inc. are both Diagnostics & Research companies. Illumina, Inc. is the larger, with a market value of $31.5B against $28.0B — 1.1× the size. Quest Diagnostics Incorporated trades at the lower P/E: 25.0× against 35.6×. Quest Diagnostics Incorporated grew revenue faster over the last twelve months: 9.13% against 5.83%. Illumina, Inc. has the higher net margin (19.7% vs 9.50%) and the higher return on invested capital (16.7% vs 8.48%). Across the 22 metrics below, Illumina, Inc. leads on 13 and Quest Diagnostics Incorporated on 9.
Valuation
Profitability
| Metric | DGX | ILMN | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 33.11% | 67.87% | 48.32% |
| Operating margin | 14.55% | 21.18% | (5.68%) |
| Net margin | 9.50% | 19.72% | (4.10%) |
| Free cash flow margin | 11.61% | 23.29% | 0.00% |
| Return on equity | 14.76% | 32.39% | 0.00% |
| Return on assets | 6.73% | 13.78% | (6.05%) |
| Return on invested capital | 8.48% | 16.70% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack